Salarius Pharmaceuticals, Inc.
SLRX
$0.84
-$0.02-2.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 46.46% | -75.71% | -58.88% | -58.74% | -56.68% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -72.09% | -77.27% | -51.76% | -46.52% | -27.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 58.66% | -61.31% | -52.28% | -54.18% | -54.08% |
|
|
|||||
| Total Current Assets | 58.66% | -61.31% | -52.28% | -54.18% | -54.08% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -12.05% | -16.79% | -35.77% | -47.09% | -54.60% |
| Total Assets | 57.99% | -60.81% | -52.10% | -54.10% | -54.08% |
|
|
|||||
| Total Accounts Payable | 565.98% | 130.43% | 105.98% | 55.42% | -84.77% |
| Total Accrued Expenses | 69.31% | 38.33% | 72.23% | -13.35% | -43.08% |
| Short-term Debt | -- | -- | -4.02% | -23.38% | -28.38% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 97.84% | 88.59% | 84.55% | 16.33% | -59.72% |
|
|
|||||
| Total Current Liabilities | 97.84% | 88.59% | 84.55% | 16.33% | -59.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -4.02% | -23.38% | -28.38% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 97.84% | 88.59% | 84.55% | 16.33% | -59.72% |
|
|
|||||
| Common Stock & APIC | 7.59% | 2.32% | 2.43% | 2.21% | 2.25% |
| Retained Earnings | -6.22% | -6.42% | -7.14% | -7.30% | -6.62% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 45.25% | -134.93% | -98.30% | -71.41% | -51.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 45.25% | -134.93% | -98.30% | -71.41% | -51.93% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 45.25% | -134.93% | -98.30% | -71.41% | -51.93% |
|
|
|||||